384 related articles for article (PubMed ID: 11565774)
1. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
2. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
[TBL] [Abstract][Full Text] [Related]
3. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
Catteau X; Simon P; Noël JC
Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
[TBL] [Abstract][Full Text] [Related]
4. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
5. High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography.
Hayes BD; Brodie C; O'Doherty A; Quinn CM
Breast J; 2013; 19(3):319-24. PubMed ID: 23600490
[TBL] [Abstract][Full Text] [Related]
6. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.
Fuhrman GM; Cederbom GJ; Bolton JS; King TA; Duncan JL; Champaign JL; Smetherman DH; Farr GH; Kuske RR; McKinnon WM
Ann Surg; 1998 Jun; 227(6):932-9. PubMed ID: 9637557
[TBL] [Abstract][Full Text] [Related]
7. Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.
Londero V; Zuiani C; Furlan A; Nori J; Bazzocchi M
Radiol Med; 2007 Sep; 112(6):863-76. PubMed ID: 17891529
[TBL] [Abstract][Full Text] [Related]
8. Predicting invasion in mammographically detected microcalcification.
Bagnall MJ; Evans AJ; Wilson AR; Pinder SE; Denley H; Geraghty JG; Ellis IO
Clin Radiol; 2001 Oct; 56(10):828-32. PubMed ID: 11895299
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma within fibroadenomas: mammographic features.
Baker KS; Monsees BS; Diaz NM; Destouet JM; McDivitt RW
Radiology; 1990 Aug; 176(2):371-4. PubMed ID: 2164233
[TBL] [Abstract][Full Text] [Related]
10. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
11. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
12. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
[TBL] [Abstract][Full Text] [Related]
15. Image-guided core breast biopsy of ductal carcinoma in situ presenting as a non-calcified abnormality.
DiPiro PJ; Meyer JE; Denison CM; Frenna TH; Harvey SC; Smith DN
Eur J Radiol; 1999 Jun; 30(3):231-6. PubMed ID: 10452723
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
17. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
[TBL] [Abstract][Full Text] [Related]
18. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
Stomper PC; Geradts J; Edge SB; Levine EG
AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
[TBL] [Abstract][Full Text] [Related]
19. Mammographic-histopathologic correlation of large-core needle biopsies of the breast.
Ioffe OB; Berg WA; Silverberg SG; Kumar D
Mod Pathol; 1998 Aug; 11(8):721-7. PubMed ID: 9720499
[TBL] [Abstract][Full Text] [Related]
20. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
